Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 18 is a member of the leucine-rich repeat (LRR) superfamily, characterized by repetitive motifs facilitating protein-protein interactions and structural scaffolding functions. The protein is predicted to regulate spermatogenesis and sperm maturation, but its precise biological role in humans remains incompletely characterized. LRRC18 is associated with certain rare genetic diseases such as autosomal recessive deafness and chromosome deletion syndromes, but there is no evidence to support its direct function as a therapeutic target or its involvement in common signaling, enzymatic, transporter, or receptor pathways. No drug interactions or biomarker roles have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 18 (LRRC18).